دورية أكاديمية

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin

التفاصيل البيبلوغرافية
العنوان: An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
المؤلفون: Poordad, Fred, Lawitz, Eric, Gutierrez, Julio A., Guerrero, Juan, Speeg, Kermit, Swenson, Eugene S.
المساهمون: Bristol-Myers Squibb
المصدر: Clinical Case Reports ; volume 5, issue 4, page 371-375 ; ISSN 2050-0904 2050-0904
بيانات النشر: Wiley
سنة النشر: 2017
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
الوصف: Key Clinical Message This case suggests that initiation of HCV therapy immediately after liver transplantation with well‐tolerated, all‐oral regimens may achieve a virologic cure in HCV ‐positive recipients, thus preventing post‐transplant HCV recurrence and associated disease progression. This strategy may broaden utilization of HCV ‐positive donor livers, potentially including HCV ‐negative transplant recipients.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1002/ccr3.841
الإتاحة: https://doi.org/10.1002/ccr3.841Test
حقوق: http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.8A9B2C6F
قاعدة البيانات: BASE